Abstract:BackgroundFDA‐approved drugs for the most common type of hair loss, androgenetic alopecia (AGA), present many side effects and disadvantages. However, herbal compounds are characterized by patient compliance, fewer side effects, and several mechanisms of action. ObjectiveThe present study set to evaluate the effectiveness and safety of the topical herbal solution and to compare it with 5% minoxidil in men with AGA. MethodsA randomized, double‐blind controlled trial was conducted from November 28, 2018, to September 2, 2019, in Sina Hospital, Tabriz, Iran. 24 healthy males (mean (SD) age 33.04 (5.81)) with mild to moderate AGA were selected from 44 volunteer participants. Participants were randomly assigned (1:1) into two groups. They received 1mL of topical solutions at morning and evening intervals for nine months. Primary outcomes consisted of measured hair diameters at baseline and repeated at weeks 12, 24, and 36. Furthermore, hair density was measured at baseline and week 36. ResultsThe MTS+THS group was significantly superior to the MTS group after 36 weeks of therapy in the hair diameter improvement. At week 36, the mean hair diameter of the MTS + THS group significantly increased compared to the MTS group (P=0.001). Hair density increased in both groups; however, only in the MTS + THS group, it was significant (P<0.05). ConclusionThe findings established that the topical herbal solution has significant influence on patients with AGA and improvement of their quality of life. This solution can be considered a significant step towards the prevention and treatment of AGA.This article is protected by copyright. All rights reserved.

Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double‐blind, randomized controlled trial study